Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Bassem Maximos"'
Autor:
Michael A. Thomas, B. Todd Chappell, Bassem Maximos, Kelly R. Culwell, Clint Dart, Brandon Howard
Publikováno v:
Contraception: X, Vol 2, Iss , Pp 100031- (2020)
Objective: The objective was to evaluate the contraceptive effectiveness, safety, and acceptability of a novel vaginal pH regulator over seven cycles of use. Study design: A single-arm, open-label, phase 3 study was conducted across 112 sites in the
Externí odkaz:
https://doaj.org/article/f0bfa0605fd1444e8001533351a193e7
Publikováno v:
Obstetrics & Gynecology. 141:64S-65S
Autor:
Mark G Martens, Bassem Maximos, Thorsten Degenhardt, Karen Person, Stacey Curelop, Mahmoud Ghannoum, Stephen Brand
Publikováno v:
Open Forum Infectious Diseases
Background Recurrent vulvovaginal candidiasis (RVVC) affects nearly 138 million women globally each year. Currently there are no FDA approved treatments. The study was conducted to evaluate the efficacy of oral oteseconazole (VT-1161) in the preventi
Autor:
Bassem Maximos, Kristina Deligiannidis, Samantha Meltzer-Brody, E. Quinn Peeper, Robert Lasser, Amy Bullock, Mona Kotecha, null Sigui li, Fiona Forrestal, Manny Garcia, Bridgette Leclair, Jim Doherty
Publikováno v:
American Journal of Obstetrics and Gynecology. 228:S272
Autor:
Mark G. Martens, Bassem Maximos, Thorsten Degenhardt, Karen Person, Stacey Curelop, Mahmoud Ghannoum, Amy Flynt, Stephen R. Brand
Publikováno v:
American Journal of Obstetrics and Gynecology. 227:880.e1-880.e11
Recurrent vulvovaginal candidiasis affects nearly 138 million women globally each year. In the United States, fluconazole is considered the standard of care for acute vulvovaginal candidiasis, but until recently there was no US Food and Drug Administ
Publikováno v:
Obstetrics & Gynecology. 139:5S-5S
Autor:
Brandon Howard, Michael A. Thomas, Clint Dart, Bassem Maximos, B. Todd Chappell, Kelly R. Culwell
Publikováno v:
Contraception: X, Vol 2, Iss, Pp 100031-(2020)
Contraception: X
Contraception: X
Objective The objective was to evaluate the contraceptive effectiveness, safety, and acceptability of a novel vaginal pH regulator over seven cycles of use. Study design A single-arm, open-label, phase 3 study was conducted across 112 sites in the Un
Publikováno v:
Obstetrics & Gynecology. 135:96S
Autor:
Lorianne Masuoka, Kimball A. Johnson, Robert Riesenberg, Bassem Maximos, Jaako Lappalainen, Alex Aimetti, Rolando Gutierrez-Esteinou
Publikováno v:
Biological Psychiatry. 85:S181-S182
Autor:
Robert Riesenberg, Stephen Kanes, Helen Colquhoun, Samantha Meltzer-Brody, David R. Rubinow, Bassem Maximos
Publikováno v:
Obstetrics & Gynecology. 131:27S-27S